Tristel PLC (TSTL.L)

GBp 390.0

(0.39%)

Market Cap (In GBp)

185.99 Million

Revenue (In GBp)

41.93 Million

Net Income (In GBp)

6.48 Million

Avg. Volume

49.82 Thousand

Currency
GBp
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
346.0-510.0
PE
-
EPS
-
Beta Value
0.195
ISIN
GB00B07RVT99
CUSIP
G9101V103
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Matthew G. Sassone
Employee Count
-
Website
https://www.tristel.com
Ipo Date
2005-06-01
Details
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand; contamination control products, which include cleanroom, laboratory, pharmaceutical, cosmetic, and toiletry disinfectants under the Crystel brand; and airborne and veterinary device disinfectants under the Anistel brand. The company was founded in 1993 and is headquartered in Snailwell, the United Kingdom.